eFFECTOR Therapeutics, Inc.

OTCPK:EFTR Voorraadrapport

Marktkapitalisatie: US$1.9k

eFFECTOR Therapeutics Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Craig Jalbert

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOless than a year
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

eFFECTOR doses first patient in second cohort of phase 1b trial of potential COVID drug

Sep 14

eFFECTOR Therapeutics GAAP EPS of -$0.17

Aug 09

eFFECTOR: Developing New Class Of Cancer Therapies

Sep 12

CEO

Craig Jalbert (62 yo)

less than a year

Tenure

Mr. Craig R. Jalbert is President, Treasurer, CS, Principal Executive Officer, Financial Officer, & Principal Accounting Officer of NexImmune, Inc. from August 27, 2024 He is Chief Executive Officer, Presi...